Literature DB >> 22623165

Neuroticism mediates the effect of P2RX7 on outcomes of mood disorders.

Outi Mantere1, Pia Soronen, Rudolf Uher, Mikko Ketokivi, Pekka Jylhä, Tarja Melartin, Tiina Paunio, Erkki Isometsä.   

Abstract

BACKGROUND: We previously reported an association between P2RX7 variant rs208294, diagnosis, and the longitudinal course of mood disorders. Here, we test whether the personality trait neuroticism mediates the effect of P2RX7 on the course of mood disorders.
METHODS: Patients with DSM-IV mood disorder (256 with major depressive disorder and 168 with bipolar disorder [BD]) were diagnosed with semistructured interviews, genotyped, and followed up for a median of 60 (range 6-83) months. The primary outcome was the prospectively assessed proportion of time spent in any DSM-IV mood episode (time ill). Three types of genetic effect were tested in structural equations models: Model 1: genes directly affect outcome independent of neuroticism, Model 2: neuroticism mediates the effect of genes on outcome, and Model 3: neuroticism and the genetic variant interact in their effect on outcome.
RESULTS: Neuroticism mediated the P2RX7 genetic effect on outcome. The T allele of rs208294 was associated with higher neuroticism, which in turn predicted a higher proportion of time spent in mood episodes (the bootstrap-based test of indirect effect, P = .02). There was no significant interaction between neuroticism and the genotype.
CONCLUSION: Neuroticism is likely to lie on the causal pathway between the rs208294 T variant and the adverse long-term course of major depressive and BDs.
© 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22623165     DOI: 10.1002/da.21945

Source DB:  PubMed          Journal:  Depress Anxiety        ISSN: 1091-4269            Impact factor:   6.505


  5 in total

Review 1.  Purinergic system dysfunction in mood disorders: a key target for developing improved therapeutics.

Authors:  Robin Ortiz; Henning Ulrich; Carlos A Zarate; Rodrigo Machado-Vieira
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2014-11-07       Impact factor: 5.067

2.  Distinct lithium-induced gene expression effects in lymphoblastoid cell lines from patients with bipolar disorder.

Authors:  Gabriel R Fries; Gabriela D Colpo; Nancy Monroy-Jaramillo; Junfei Zhao; Zhongming Zhao; Jodi G Arnold; Charles L Bowden; Consuelo Walss-Bass
Journal:  Eur Neuropsychopharmacol       Date:  2017-09-20       Impact factor: 4.600

Review 3.  Neuroimmune signaling in alcohol use disorder.

Authors:  Emma K Erickson; Emily K Grantham; Anna S Warden; R A Harris
Journal:  Pharmacol Biochem Behav       Date:  2018-12-24       Impact factor: 3.533

Review 4.  P2X and P2Y receptors—role in the pathophysiology of the nervous system.

Authors:  Kamila Puchałowicz; Maciej Tarnowski; Irena Baranowska-Bosiacka; Dariusz Chlubek; Violetta Dziedziejko
Journal:  Int J Mol Sci       Date:  2014-12-18       Impact factor: 5.923

Review 5.  Beyond Seizure Control: Treating Comorbidities in Epilepsy via Targeting of the P2X7 Receptor.

Authors:  Beatriz Gil; Jonathon Smith; Yong Tang; Peter Illes; Tobias Engel
Journal:  Int J Mol Sci       Date:  2022-02-21       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.